Altogether, our results reinforce the idea that IFNs cause pain by acting on nociceptors and explain, mechanistically, how chemotherapeutics that are STING activators and microtubule destabilizers such as vinorelbine have the potential to cause pain and peripheral neuropathy. This evidence concerns the gene STING1 and peripheral neuropathy.